project id: TCGA-CESC; case submitter id: TCGA-DS-A7WF; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.82; rna integrity number: 8.9; age at index: 41; days to birth: -15319; days to death: 492; ethnicity: hispanic or latino; gender: female; race: not reported; vital status: Dead; year of birth: 1965; year of death: 2007; age at diagnosis: 15319; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic t: T1b2; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8560/3; primary diagnosis: Adenosquamous carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 0.3835616438356164; pack years smoked: 7.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 2483; days to sample procurement: 0; initial weight: 230.0; portion submitter id: TCGA-DS-A7WF-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;